 experiment treatment benign prostat hyperplasia transurethr balloon dilat prostat preliminari studi human prospect studi safeti potenti efficaci transurethr balloon cathet dilat prostat tudp treatment benign prostat hyperplasia bph subject moder symptom sign prostat basi quantit symptom score SS uroflowmetri measur residu urin volum seven patient urinari retent mean age year rang year tudp patient signific complic mean follow-up month rang month forty-six patient improv SS recent follow-up patient SS prostatectomi subject reduct mean residu urin volum signific patient median lobe enlarg improv SS other author tudp safe effect ultim demonstr effect control clinic trial